secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2022-06-17T23:59:59+00:00
Accession:  0001104659-22-072444
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma director Gregory Oakes resigns; board lowers quorum to one-third
--------------------------------------------------------------------------------

- Gregory Oakes resigned from the Board effective June 16, 2022; no disagreement cited.
- Board amended bylaws to reduce stockholder meeting quorum from majority to one-third of voting power.
- Company filed Certificate of Correction clarifying Board's right to designate preferred stock series with/without voting powers, effective retroactively to July 13, 2016.
- Exhibits 3.1 (bylaw amendment) and 3.2 (Certificate of Correction) filed with the SEC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465922072444/0001104659-22-072444-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465922072444/tm2218808d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-072444

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer